One whole genome. Two purpose-built testing platforms.

MyOme Atlas is a proactive risk screening solution that analyzes whole-genome sequencing combined with clinical risk factors to map comprehensive health risks and guide personalized care. A patient's health risk profile can be reanalyzed throughout their lifetime, revealing new insights as their health journey evolves and technology advances.

• Curated Screen™: up to 151 genes across 40+ health conditions
• Medication Response™: insights across 70+ medications
• Integrated Polygenic Risk Scores for cardiometabolic and cancer risk

Identify the genetic cause of undiagnosed conditions with exome- and genome-based diagnostic testing built to shorten the diagnostic odyssey.

• Rare Disease Exome: protein-coding regions of the genome
• Rare Disease Genome: coding and non-coding regions for the most comprehensive assessment
• Rare Disease Copy Number Analysis: genome-wide copy number variants